Renal function is associated with arterial stiffness and predicts outcome in patients with coronary artery disease

被引:25
作者
Ilyas, B. [1 ]
Dhaun, N. [1 ]
Markie, D. [1 ]
Stansell, P. [1 ]
Goddard, J. [2 ]
Newby, D. E. [3 ]
Webb, D. J. [1 ]
机构
[1] Univ Edinburgh, Clin Pharmacol Unit, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland
[2] Royal Infirm, Dept Renal Med, Edinburgh EH16 4TJ, Midlothian, Scotland
[3] Royal Infirm, Dept Cardiol, Edinburgh EH16 4TJ, Midlothian, Scotland
基金
英国惠康基金;
关键词
CHRONIC KIDNEY-DISEASE; PULSE-WAVE VELOCITY; CREATININE CLEARANCE; AORTIC STIFFNESS; MORTALITY; IMPACT; DYSFUNCTION; RISK; SURVIVAL; POPULATION;
D O I
10.1093/qjmed/hcn171
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background: Arterial stiffness (AS) is associated, and a predictor of, outcome in patients with cardiovascular and renal disease. Aim: In this study, we estimated glomerular filtration rate (eGFR) and measured indices of AS in patients with suspected coronary artery disease (CAD), and assessed their predictive value on outcome. Design: Prospective cohort study. Methods: AS was measured using pulse wave velocity (PWV) and pulse wave analysis in patients with no known renal disease who had recently undergone coronary angiography. Renal function was assessed using serum creatinine concentration [creat](sr) and eGFR (Cockcroft Gault, CG). The primary endpoint was a combination of hospitalization due to cardiovascular disease and all-cause mortality. Results: Two hundred eighty-four subjects (210 men, 74 women, mean age 62 years) were followed-up for a mean of 1.5 years. PWV was negatively associated with eGFR (r(2) 0.09, P 0.001), even in patients with an eGFR 60 ml/min/m(2) (r(2) 0.04, P 0.01). PWV was determined by age, heart rate, systolic blood pressure, body mass index and [creat](sr) (r(2) 0.38, P 0.001). A lower eGFR (P 0.01), PWV above the median (P 0.05) and degree of CAD (P 0.001) predicted a shorter time to the primary endpoint. eGFR and degree of CAD remained independent determinants of outcomes (P 0.01), even in patients with normal renal function (P 0.01). Conclusions: This study suggests that even minor reductions in eGFR, within the normal range, are an additional independent risk marker in patients with CAD.
引用
收藏
页码:183 / 191
页数:9
相关论文
共 36 条
[1]
Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365
[2]
Impact of renal failure on the risk of myocardial infarction and death [J].
Beddhu, S ;
Allen-Brady, K ;
Cheung, AK ;
Horne, BD ;
Bair, T ;
Muhlestein, JB ;
Anderson, JL .
KIDNEY INTERNATIONAL, 2002, 62 (05) :1776-1783
[3]
Impact of aortic stiffness on survival in end-stage renal disease [J].
Blacher, J ;
Guerin, AP ;
Pannier, B ;
Marchais, SJ ;
Safar, ME ;
London, GM .
CIRCULATION, 1999, 99 (18) :2434-2439
[4]
Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease [J].
Briet, M ;
Bozec, E ;
Laurent, S ;
Fassot, C ;
London, GM ;
Jacquot, C ;
Froissart, M ;
Houillier, P ;
Boutouyrie, P .
KIDNEY INTERNATIONAL, 2006, 69 (02) :350-357
[5]
Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease [J].
Chirinos, JA ;
Zambrano, JP ;
Chakko, S ;
Veerani, A ;
Schob, A ;
Willens, HJ ;
Perez, G ;
Mendez, AJ .
HYPERTENSION, 2005, 45 (05) :980-985
[6]
PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[7]
Impact of renal dysfunction on outcomes of coronary artery bypass surgery - Results from the Society of Thoracic Surgeons National Adult Cardiac Database [J].
Cooper, WA ;
O'Brien, SM ;
Thourani, VH ;
Guyton, RA ;
Bridges, CR ;
Szczech, LA ;
Petersen, R ;
Peterson, ED .
CIRCULATION, 2006, 113 (08) :1063-1070
[8]
DUBOIS D, 1989, NUTRITION, V5, P303
[9]
Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States medicare population, 1998 to 1999 [J].
Foley, RN ;
Murray, AM ;
Li, SL ;
Herzog, CA ;
McBean, AM ;
Eggers, PW ;
Collins, AJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (02) :489-495
[10]
The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial [J].
Fox, Keith A. A. ;
Antman, Elliott M. ;
Montalescot, Gilles ;
Agewall, Stefan ;
SomaRaju, Bhupathi ;
Verheugt, Freek W. A. ;
Lopez-Sendon, Jose ;
Hod, Hanoch ;
Murphy, Sabina A. ;
Braunwald, Eugene .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (23) :2249-2255